Delivering Team-Based Preventive Health Maintenance in IBD: Wrap-Around Interdisciplinary Care
Adaptive Learning
Premiere Date: Thursday, December 29, 2022This activity offers CE credit for:
%>- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Creditâ„¢
Credit Expiration Date:
Friday, December 29, 2023
Note: Credit Is No Longer Available
Anita Afzali, MD, MPH, MHCM, FACG, AGAF Professor of Clinical Medicine Interim Chief, Division of Digestive Diseases Executive Vice Chair, Department of Internal Medicine University of Cincinnati College of Medicine Associate Chief Medical Officer, UC Health System Cincinnati, OH |
Studies have shown that patients with inflammatory bowel disease (IBD) are less likely than patients without IBD to receive needed preventive health maintenance. Effective preventive measures are critical in reducing morbidity, hospitalization, and surgery as well as improving disease-free remission and quality of life in patients with IBD. It is key for clinicians working in both primary care and gastroenterology settings to understand the preventive health maintenance needs of their patients with IBD. Clinicians should tailor their approach based on patient age as preventive health guidelines and vaccination guidelines are age specific. As 25% of patients with IBD are diagnosed before age 20, it is critical that providers be aware of screening recommendations specific to the pediatric patient population.
After completion of this Adaptive Learning OnDemand activity developed by Dr. Anita Afzali, learners will be able to manage and maintain patient vaccinations, perform appropriate and regular screenings for cancer and depression/anxiety, and effectively provide age-specific preventive care for patients with IBD by using current guidelines and a team-based approach.
At the end of this CE activity, participants should be able to:
- Integrate recommended vaccinations into gastroenterology clinical practice to improve health outcomes for patients with IBD, especially older adults.
- Develop a health screening plan for patients with IBD, including cancer, bone health, and depression/anxiety screenings.
- Implement a team-based approach to preventive care management for pediatric patients with IBD.
Supported by an educational grant from Pfizer Inc.
Community gastroenterologists, PAs, nurse practitioners, pharmacists, primary care physicians, and pediatricians
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring material
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
Dr. Afzali reports the following financial relationships:
Consultant: Abbvie Inc.; Arena Pharmaceuticals, Inc.; Bristol Myers Squibb; DiaSorin Molecular LLC; Eli Lilly and Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals; Pfizer Inc.; Takeda Pharmaceutical Company; and TLL Pharmaceuticals.
Grants: AbbVie Inc.; Bristol Myers Squibb; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceutical Company.
Other financial or material support: Co-Founder, Board Member; IBD Horizons; Co-Founder, Board Member; Scrubs & Heels, LLC.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
AL-003-122922-02